ImageneBio
Yahoo Finance • 6 days ago
ImageneBio to Participate in Fourth Quarter 2025 Investor Conferences
SAN DIEGO, Nov. 06, 2025 (GLOBE NEWSWIRE) -- ImageneBio, Inc. (Nasdaq: IMA, “Imagene,” “Company”), a clinical-stage biotechnology company developing therapeutics for patients with immunological, autoimmune and inflammatory diseases, incl... Full story
Yahoo Finance • 2 months ago
ImageneBio files to sell 2.51M shares of common stock for holders
* ImageneBio (NASDAQ:IMA [https://seekingalpha.com/symbol/IMA]) filed to sell 2.51M common stock shares for holders. * This preliminary prospectus is not an offer to sell. * Filing [https://seekingalpha.com/filing/10396516] MORE ON... Full story
